NCT00228631View on ClinicalTrials.gov

Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2011

Study Completion Date

July 31, 2012

Conditions
Sickle Cell Disease
Trial Locations (1)

30322

Children's Healthcare of Atlanta, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT00228631 - Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD | Biotech Hunter | Biotech Hunter